EUVIMEDEUVIMED entdecken
Crossref

Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic

Perković Dijana, Petrić Marin iD, Petra Šimac iD, Vodanović Ana iD, Borić Katarina iD, Gugo Katarina iD, Tandara Leida iD

Rheumatology International · 2024

DOI: 10.1007/s00296-024-05596-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology International, 2024. Verfasst von Perković Dijana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology and Clinical Immunology, Department of Internal medicine, University hospital of Split, Šoltanska 1, Split, Croatia. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Antineutrophil Cytoplasmic, SARS-CoV-2. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Antibodies, Antineutrophil CytoplasmicSARS-CoV-2HumansIncidenceFemaleMaleMiddle AgedAgedAdultAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisPandemics

Substanzen

Antibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Division of Rheumatology and Clinical Immunology, Department of Internal medicine, University hospital of Split, Šoltanska 1, Split, Croatia.
  • Department of Internal Medicine, School of Medicine, University of Split, Šoltanska 2, Split, Croatia.
  • Division of Rheumatology and Clinical Immunology, Department of Internal medicine, University hospital of Split, Šoltanska 1, Split, Croatia. marin.petric2017@gmail.com.
  • Department of Medical Laboratory Diagnostics, University hospital of Split, Šoltanska 1, Split, Croatia.
  • Laboratory Diagnostics Department, School of Medicine, University of Split, Šoltanska 2, Split, Croatia.

ORCID-Profile: Petrić Marin, Petra Šimac, Vodanović Ana, Borić Katarina, Gugo Katarina, Tandara Leida

Zitieren

APA

Dijana, P., Marin, P., Šimac, P., Ana, V., Katarina, B., Katarina, G., & Leida, T. (2024). Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic. Rheumatology International. https://doi.org/10.1007/s00296-024-05596-3

Vancouver

Dijana P, Marin P, Šimac P, Ana V, Katarina B, Katarina G, et al. Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic. Rheumatology International. 2024. doi:10.1007/s00296-024-05596-3

BibTeX
@article{Dijana2024,
  author = {Dijana, Perković and Marin, Petrić and Šimac, Petra and Ana, Vodanović and Katarina, Borić and Katarina, Gugo and Leida, Tandara},
  title = {Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic},
  journal = {Rheumatology International},
  year = {2024},
  doi = {10.1007/s00296-024-05596-3}
}
Kostenlos starten →